GH/IGF-1 axis is one of the main regulator of both bone modeling and remodeling. Therefore, GH deficient (GHD) patients have a derangment in these processes leading to impaired linear growth with delayed stature, reduced peak bone acquisition, reduced bone size, decrease in bone turnover, low bone mass, osteoporosis and increased fracture risk in adults. GH replacement therapy can restore a normal bone linear growth in children and can improve bone mass, reducing the fractures in GHD patients, whereas its application in treating osteoporosis in non-GHD patients is still controversial.
Osteoporosis in GH deficiency
Triggiani v
;Guastamacchia e;
2019-01-01
Abstract
GH/IGF-1 axis is one of the main regulator of both bone modeling and remodeling. Therefore, GH deficient (GHD) patients have a derangment in these processes leading to impaired linear growth with delayed stature, reduced peak bone acquisition, reduced bone size, decrease in bone turnover, low bone mass, osteoporosis and increased fracture risk in adults. GH replacement therapy can restore a normal bone linear growth in children and can improve bone mass, reducing the fractures in GHD patients, whereas its application in treating osteoporosis in non-GHD patients is still controversial.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Preprint GHD and osteoporosis Mancini EDs.pdf
non disponibili
Tipologia:
Documento in Versione Editoriale
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
1.69 MB
Formato
Adobe PDF
|
1.69 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
